Phosphodiesterase-5 inhibitors not tied to alzheimer disease risk

Oct 19, 2022

Phosphodiesterase-5 (PDE5) inhibitors seem not to be associated with a reduced risk for Alzheimer disease and related dementia, according to a study published online Oct. 4 in Brain Communications.

Harsh discipline increases risk of children developing lasting mental health problems, shows study
Parents who frequently exercise harsh discipline with young children are putting them at significantly greater risk of developing lasting mental health problems, new evidence shows.
New IVF method: More expensive, not more effective
The use of time-lapse monitoring in IVF does not result in more pregnancies or shorten the time it takes to get pregnant. This new method, which promises to "identify the most viable embryos," is more expensive than the classic approach. Research from Amsterdam UMC, published today in The Lancet, shows that time-lapse monitoring does not improve clinical results.
Six things to know about multiple sclerosis
Multiple sclerosis (MS) is a disorder of the nervous system that affects about 1 million people in the United States. It usually begins between the ages of 20 and 40 and is the most common disabling neurological disorder of young adults.
Those who support Black Lives Matter tend to be less hesitant about vaccines, study finds
Efforts to encourage vaccination might do well to take advantage of the positive feelings and actions between different social groups, according to a study of attitudes toward vaccines among supporters of the Black Lives Matter movement.
Finding the origin of congenital coronary fistulae
Scientists of the Department of Animal Biology of the University of Malaga have discovered the cellular mechanism that originates coronary arterio-ventricular fistulae, a congenital anomaly that, in severe cases, may result in death.

Generated by Feedzy

Phosphodiesterase-5 inhibitors not tied to alzheimer disease risk

Recent Posts

JUST IN